Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Lifestyle factors associated with a rapid decline in the estimated glomerular filtration rate over two years in older adults with type 2 diabetes–Evidence from a large national database in Japan

  • Yaya Li,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Makoto Fujii,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Validation

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Yuko Ohno,

    Roles Conceptualization, Data curation, Methodology, Project administration, Resources, Supervision

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Asuka Ikeda,

    Roles Conceptualization, Data curation, Methodology, Project administration, Validation

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Kayo Godai,

    Roles Conceptualization, Data curation, Methodology, Project administration, Supervision

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Yuko Nakamura,

    Roles Conceptualization, Data curation, Validation

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Yuya Akagi,

    Roles Data curation

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Daisuke Yabe,

    Roles Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan

  • Kazuyo Tsushita,

    Roles Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Graduate Schools of Nutrition Sciences, Kagawa Nutrition University, Saitama, Sakado, Japan

  • Naoki Kashihara,

    Roles Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan

  • Kei Kamide,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

  • Mai Kabayama

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

    kabayama@sahs.med.osaka-u.ac.jp

    Affiliation Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan

Abstract

Background

The present study investigated lifestyle risk factors from metabolic syndrome-related lifestyles for a rapid decline in the estimated glomerular filtration rate (eGFR) among adults aged 40–74 years with treated and untreated type 2 diabetes.

Methods and results

This study analyzed data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan, encompassing the period from fiscal year (FY) 2017 to FY2020. We established FY2018 as our baseline year. The subjects of this study were adults aged 40–74 in FY2018(baseline) who had type 2 diabetes and underwent specific health checkups in FY2020. We excluded adults with a medical record of kidney dialysis between FY2017 and FY2018, records of suspected type 1 diabetes between FY2017 and FY2020, or a baseline eGFR >85 mL/min/1.73 m2 or missing eGFR data as of FY2020. Eventually we analyzed 573,860 individuals. The outcome variable was a rapid decline in eGFR (≥30%) during the follow-up. Exposure lifestyle factors included skipping breakfast, late-night dinners, regular smoking, a high alcohol intake, non-refreshing sleep, and a lack of habitual exercise. Logistic regression models were stratified by age (40–59 and 60–74 years) and baseline eGFR levels (60–85, 30–59, and <30 mL/min/1.73 m2). Covariates included sex, a history of heart disease, a history of stroke, a history of renal failure, anemia, low-density lipoprotein, systolic blood pressure, hemoglobin A1C, body mass index, antidiabetic medications, antihypertension drugs, lipid-lowering drugs, the oral adsorbent Kremezin, non-steroidal anti-inflammatory drugs, and drugs for the treatment of renal anemia. A rapid decline in eGFR was detected in approximately 1.3% of participants (7,683 cases). In the baseline eGFR >30 subgroups (60–85 or 30–59 mL/min/1.73 m2), skipping breakfast and regular smoking were associated with a rapid decline in eGFR in both age groups, while a lack of habitual exercise and late-night dinners in the 60–74 age group and non-refreshing sleep in the 40–59 age group were identified as risk factors. Additionally, skipping breakfast was a risk factor for a rapid decline in eGFR in the 60–74 age group regardless of baseline eGFR levels. In the baseline eGFR <30 mL/min/1.73 m2 subgroup, skipping breakfast and non-refreshed sleep were risk factors for a rapid decline in eGFR.

Conclusions

We found specific lifestyle risk factors were associated with a rapid eGFR decline among people with type 2 diabetes from a nationwide database in Japan. The associations varied by baseline eGFR level, age, and sex. Lifestyle modifications may effectively prevent the aggravation of diabetic kidney disease.

Introduction

The increasing prevalence of diabetes is a global public health issue [1] and is associated with a wide range of complications, among which renal disease is one of the most impactful. Diabetes is one of the main causes of end-stage renal disease globally [2]. Besides the high financial cost for public health and the long-term care burden for family members, end-stage renal disease causes a lifelong reduction in quality of life. In Japan, diabetic kidney disease is the leading cause of dialysis (39.5%) and its rate has been increasing [3].

The etiology of type 2 diabetes is complex and multifactorial, as it is influenced by genetic predisposition, aging, and lifestyle factors. Among these, exposure to unhealthy lifestyle habits is preventable and there is a set of recommended lifestyles in Japan to improve metabolism. However, lifestyle factors have rarely been reported in the context of risk factors for the aggravation of diabetic kidney disease [4, 5]. This may be attributed to the difficulties associated with interventions for patients with aggravated diabetic kidney disease and the lack of large-scale data on renal function in the general population, not just treated patients with a diagnosis of diabetes.

Therefore, the present study investigated lifestyle risk factors for renal dysfunction from metabolic syndrome-related lifestyles in Japan by conducting a large-scale cohort analysis of Japanese adults with treated and untreated type 2 diabetes. We collected specific health checkups data on eGFR from a large national database between fiscal year (FY) 2018 (baseline) and FY2020 (follow-up) as renal dysfunction markers. The results obtained herein may facilitate the development of effective strategies to prevent the deterioration of renal function among adults with type 2 diabetes.

Materials and methods

Data source

The present study used the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), which is operated by the Ministry of Health, Labour and Welfare (MHLW) to collect nationwide health insurance claims data and specific health checkups data annually. Specific health checkups are conducted annually for people aged 40–74 years who are covered by the national health insurance system. In Japan, the majority of residents are covered by the universal health insurance system and have access to medical and health care services, such as specific health checkups [6]. Therefore, NDB data mostly covers residents who have received medical and health care services in Japan [7]. The NDB is accessible with strict conditions. We obtained permission from the MHLW to use the anonymized NDB dataset between FY2017 and FY2020 for the purpose of the present study. The present study was approved by the Osaka University Clinical Research Review Committee (approval number 20,530[T4]-2).

Study population

The subjects of this study were adults aged 40–74 in FY2018 who had type 2 diabetes and who underwent specific health checkups in FY2020. The definition of type 2 diabetes at baseline included (1) fasting blood glucose level ≥126 mg/dL, (2) non-fasting blood glucose level ≥200 mg/dL, (3) hemoglobin A1c (HbA1c) ≥6.5%, (4) self-reported current use of hypoglycemic agents, or (5) medical claims for anti-diabetes treatments. We excluded adults with medical claims for kidney dialysis between FY2017 and FY2018 or medical claims for suspected type 1 diabetes between FY2017 and FY2020. Adults with a baseline eGFR >85 mL/min/1.73 m2 or missing eGFR data as of FY2020 were also excluded. Overall, we analyzed 573,860 individuals (Fig 1). The NDB contains most of the health insurance claims data of residents enrolled in the national health insurance system. Since these data rarely include non-Japanese residents [8], it may be inferred that the majority of participants in the present study were Japanese.

Assessments

The outcome variable in the present study was the incidence of a rapid decline in eGFR in the follow-up (FY2020). eGFR data are automatically calculated in the specific health checkups system based on a widely used equation modified by the Japanese Society of Nephrology for Japanese populations [9]:

eGFR (mL/min/1.73 m2) = 194 × Serum creatinine-1.094 × Age-0.287 × 0.739 (if female)

We calculated the rate of decline (%) in eGFR using the following equation and defined a ≥30% rate of decline in eGFR during FY2018-FY2020 as a “rapid eGFR decline” [10]:

Exposure variables in the present study included the following lifestyle risk factors that were measured using a standardized self-administered questionnaire designed by the MHLW [11] (a copy of relevant questions on lifestyle variables from the questionnaire is provided in S1 Table): (1) regular smoking (more than 100 cigarettes in total or more than a 6-month history and smoking in the past month), (2) a high alcohol intake (more than 20 g/day for females or more than 40 g/day for males), (3) skipping breakfast (more than 3 days a week), (4) late-night dinners (eating dinner within 2 hours before bedtime more than 3 days a week), (5) a lack of habitual exercise (light exercise for more than 30 minutes twice a week for more than 1 year), and (6) non-refreshing sleep (self-reported). These lifestyle risk factors were treated as dichotomous variables (yes/no).

Covariates included baseline data on sex (male/female), a history of heart disease (yes/no), a history of stroke (yes/no), a history of renal failure (yes/no), anemia (yes/no), body mass index (BMI) (<18.5/18.5–24.9/≥25.0), low-density lipoprotein (<140/≥140 mg/dL.), systolic blood pressure (<130/≥130 mmHg), HbA1c (<7/≥7%), antidiabetic medications (including Sodium-glucose co-transporter-2[SGLT2] inhibitors, Glucagon-like peptide-1 receptor agonist[GLP-1RAs], Biguanides, Thiazolidinediones, Sulfonylureas, Glinides, Dipeptidyl peptidase-4 inhibitors, α-glucosidase inhibitors, or insulin: yes/no), antihypertension medications (Angiotensin-converting enzyme inhibitors[ACEIs], Angiotensin II receptor blockers[ARBs] or others: yes/no), lipid-lowering medications (yes/no), the oral adsorbent Kremezin (yes/no), non-steroidal anti-inflammatory medications (yes/no), or medications for the treatment of renal anemia (yes/no).

Analyses

Differences in baseline characteristics between subjects showing rapid and non-rapid declines in eGFR were examined using chi-square tests. We used adjusted logistic regression models to analyze relationships between lifestyle risk factors at baseline and a rapid eGFR decline two fiscal years later. All exposure variables (lifestyle risk factors) were simultaneously entered into logistic regression models together with all the covariates. Logistic regression models were stratified by age (40–59 and 60–74 years) and baseline eGFR levels (60–85, 30–59, and <30 mL/min/1.73 m2). These stratified models were not further adjusted for age or baseline eGFR. We further conducted sub-group analyses by sex (S2 Table). Considering urine protein relevant with eGFR mostly, we conducted additional stratified logistic analyses by baseline urine protein levels assessed by the qualitative urine dipstick test (<1+ or ≥1+) (S3 Table). We also analyzed the lifestyle score which was defined by the total number of lifestyle risk factors ranges from 0 to 6 (regular smoking, a high alcohol intake, skipping breakfast, late-night dinners, a lack of habitual exercise, and non-refreshing sleep) to assess the relationship between the lifestyle score and a rapid eGFR decline (S4 Table). Since cardiovascular events are likely to be affected by lifestyle factors and frequent among adults with type 2 diabetes, we defined a new case of cardiovascular disease during the 2-year follow-up period from baseline as a cardiovascular event and then combined the cardiovascular event and rapid eGFR decline categories (only a cardiovascular event; only a rapid eGFR decline; both a cardiovascular event and rapid eGFR decline, neither a cardiovascular event nor a rapid eGFR decline). We then conducted a multinomial logistic regression using neither a cardiovascular event nor a rapid eGFR decline as the reference group (S5 Table). We also categorized eGFR decline rates at the 2-year follow-up into four groups: minimal progression (<10%), slow progression (≥10 and <20%), medium progression (≥20 and <30%), and rapid progression (≥30%). Using the minimal progression group as the reference, we conducted a multinomial logistic regression for the slow, medium, and rapid progression groups (S6 Table). Missing values were not imputed. We reported odds ratios (OR) and 95% confidence intervals (95% CI). Statistical analyses were performed using Stata MP 17.0.

Results

Table 1 shows baseline demographics and lifestyle risk factors in the study population of 573,860 participants, with 566,177 in the non-rapid decline group (98.66%) and 7683 in the rapid decline group (1.34%).

thumbnail
Table 1. Selected demographics and lifestyle risk factors at baseline.

https://doi.org/10.1371/journal.pone.0295235.t001

Table 2 shows the relationships between lifestyle risk factors and a rapid eGFR decline after 2 fiscal years according to baseline eGFR subgroups. Among participants aged 40–59 years, we identified three lifestyle risk factors that caused a rapid decline in the baseline eGFR: skipping breakfast (OR, 1.57; 95% CI, 1.34–1.84 in the eGFR 60–85 subgroup), regular smoking (OR, 1.29; 95% CI, 1.12–1.50 in the eGFR 60–85 subgroup; OR, 1.45; 95% CI, 1.21–1.73 in the eGFR 30–59 subgroup), and non-refreshing sleep (OR, 1.19; 95% CI, 1.00–1.42 in the eGFR 30–59 subgroup; OR, 1.36; 95% CI, 1.00–1.85 in the eGFR <30 subgroup). A high alcohol intake was negatively associated with a rapid eGFR decline 2 years later (OR, 0.75; 95% CI, 0.59–0.95 in the eGFR 30–59 subgroup). In the 60–74 age group, a relationship between skipping breakfast and a higher risk of a rapid eGFR decline was observed in all baseline eGFR subgroups (OR, 1.32; 95% CI, 1.07–1.63 in the eGFR 60–85 subgroup; OR, 1.35; 95% CI, 1.06–1.70 in the eGFR 30–59 subgroup; OR, 1.88; 95% CI, 1.15–3.09 in the eGFR <30 subgroup). Regular smoking (OR, 1.40; 95% CI, 1.20–1.63 in the eGFR 60–85 subgroup; OR, 1.84; 95% CI, 1.55–2.17 in the eGFR 30–59 subgroup) and a lack of habitual exercise (OR, 1.21; 95% CI, 1.06–1.39 in the eGFR 60–85 subgroup; OR, 1.48; 95% CI, 1.26–1.74 in the eGFR 30–59 group) were identified as lifestyle risk factors in the baseline eGFR ≥30 subgroup. Late-night dinners (OR, 1.22; 95% CI, 1.03–1.45) were associated with a rapid eGFR decline in the baseline eGFR 30–59 subgroup.

thumbnail
Table 2. Relationships between lifestyle risk factors and a rapid eGFR decline in adults with type 2 diabetes and different baseline eGFR levels.

https://doi.org/10.1371/journal.pone.0295235.t002

Discussion

To identify lifestyle risk factors contributing to the deterioration of diabetic kidney disease, we examined the effects of metabolic syndrome-related lifestyles, which were used as guidance for metabolic health management in Japan, on a rapid eGFR decline in a large type 2 diabetic population with normal or abnormal baseline eGFR levels. In the baseline eGFR >30 subgroups (60–85 or 59–30 mL/min/1.73 m2), skipping breakfast and regular smoking were associated with a rapid eGFR decline in both age groups. A lack of habitual exercise and late-night dinners were the only risk factors in the 60–74 age group, while non-refreshing sleep was the only risk factor in the 40–59 age group. In the baseline eGFR <30 mL/min/1.73 m2 subgroup, only skipping breakfast and non-refreshed sleep were associated with the risk of a rapid decline in eGFR. Our study further revealed that in the subgroup with urine protein levels < 1+, a higher number of lifestyle factors were significantly correlated with a rapid eGFR decline compared to the subgroup with urine protein levels ≥1+. Moreover, while the relationships between certain lifestyle factors (non-refreshed sleep, regular smoking, skipping breakfast) and renal function decline varied depending on urinary protein levels, the associations of skipping breakfast with a rapid eGFR decline in the 40–59 age group were consistent across different urine subgroups.

There are several hypotheses in previous literature for the effects of these lifestyle risk factors on renal function. One prevailing notion is the adverse effects of these lifestyle risk factors on glycemic control or insulin sensitivity, which, in turn, affect glomerular hemodynamics [1215]. Another argument is that these lifestyle risk factors increase the risk of cardiovascular disease, which is also a major risk factor aggravating renal disease [14, 1621]. However, the direct relationships between these lifestyle risk factors and renal function remain unclear. We herein showed that the relationships between lifestyle risk factors and a rapid eGFR decline remained significant in different subgroups after adjustments for HbA1c levels and cardiovascular disease. Although we were unable to adjust for all the glycemic indicators and cardiovascular disease, we speculate that these lifestyle risk factors may be associated with specific mechanisms related to glomerular filtration, as discussed below.

Skipping breakfast

We herein focused on the effects of skipping breakfast on future eGFR levels because it was identified as a risk factor in both age groups. This association was found to be present regardless of baseline eGFR levels in the 60–74 age group. Consistent with previous findings [22, 23], a relationship was observed between skipping breakfast and the risk of a decline in renal function. Previous studies reported that specific mechanisms may be responsible for the effects of eating breakfast on metabolic health/diabetes progression, and may contribute to the relationship between breakfast and renal function [16, 24]. Furthermore, the effects of skipping breakfast on blood glucose stability were found to be long-lasting, such that postprandial hyperglycemia may persist for the remainder of the day [25, 26]. We also speculated that skipping breakfast may be associated with dehydration and low nutrition [27]. However, the direct mechanisms responsible for the relationship between skipping breakfast and a decline in eGFR needs to be elucidated in future studies. Moreover, although the number of participants in the eGFR <30 subgroup were small, skipping breakfast appeared to have a more profound effect on progression to an advanced eGFR deterioration stage because a markedly large increase was observed in the eGFR <30 subgroup (OR, 1.32; 95% CI, 1.07–1.63 in the eGFR 60–85 subgroup; OR, 1.35; 95% CI, 1.06–1.70 in the eGFR 30–59 subgroup; OR, 1.88; 95% CI, 1.15–3.09 in the eGFR <30 subgroup).

Regular smoking

Regular smoking is an important modifiable lifestyle risk factor for healthcare policies and is included in the guidelines for chronic kidney disease [28]. However, few studies have specified a regular smoking-induced decline in renal function among adults with type 2 diabetes [29, 30]. Besides the reported risk factors for cardiovascular disease and insulin resistance [14, 31], regular smoking may directly damage the renal vasculature through endothelial cell dysfunction, advanced glycation end products, and other non-hemodynamic changes [13, 14]. The present results are consistent with previous findings and revealed independent relationships between regular smoking and a rapid eGFR decline in both age groups with a higher risk in the 60–74 age group. Furthermore, after a sub-analysis of sex differences, we confirmed the relationship between smoking and an increased risk of a rapid eGFR decline in both males and females with baseline eGFR ≥30 and in males aged 40–59 years with baseline eGFR <30. However, the precise mechanisms for these differences remain unclear.

Lack of habitual exercise

In adults with type 2 diabetes aged 60–74 years, a rapid eGFR decline was associated with a lack of habitual exercise (light exercise for more than 30 minutes twice a week for more than 1 year) in the baseline eGFR >30 subgroups, with a higher OR in the lower baseline eGFR subgroups. Although the sample population differed from the present study, previous studies reported that eGFR may be independent of insulin but associated with cardiopulmonary fitness [32]. Exercise is beneficial for vascular complications in adults with type 2 diabetes through improvements in endothelial vasodilator function, arterial stiffness, left ventricular diastolic function, and system inflammation [33]. Although exercise capacity decreased with reductions in renal function, the present results indicate that habitual moderate exercise is essential for preventing declines in eGFR, even after its deterioration in older adults with type 2 diabetes. However, it is important to note that there may be a threshold for the benefits of exercise on renal vascular function because high-intensity exercise may be stressful [34]. A lack of exercise did not appear to be a risk factor for a rapid eGFR decline in the 45–59 age group. We speculate that a rapid eGFR decline in the 45–59 age group may be attributed to other factors. Furthermore, individuals with an exercise habit in the present study may have a better long-term cardiorespiratory capacity. Our sex analysis showed that this relationship was only present among males, which may need to be clarified in future studies.

Late-night dinners

Previous studies identified late-night dinners as a risk factor for chronic kidney disease [35]. In the baseline eGFR 30–59 subgroup, a relationship was observed between late-night dinners (eating dinner within 2 hours before bedtime more than 3 days a week) and a rapid eGFR decline in the 60–74 age group. The effects of dinner time on renal function appear to be unique in the older population. Since there is currently no clear explanation for the direct relationship between late-night dinners and eGFR, we speculate that it may be affected by atherosclerosis as an intermediate variable in older adults. A recent review provided strong evidence for hypertension and atherosclerosis being associated with late-night dinners [36]. Another interesting relationship could be that those who are eating late-night dinners may lack of health literacy or be unhealthier in general.

Non-refreshing sleep

Our research has yielded significate associations between non-refreshing sleep and a rapid eGFR decline in the 40–59 age group with baseline eGFR <60. There have been prior studies that reported poor sleep quality, such as a short sleep duration, was associated with a decline in eGFR [37, 38]. The potential mechanisms behind this correlation could be multifaceted. Non-refreshing sleep may connect with physical or mental fatigue, increased sympathetic nervous system activity, or inflammation [39]. Our study suggested the importance of restful sleep, particularly for individuals aged 40–59 who are already showing reduced eGFR. Future studies are needed to confirm these findings and the underlying mechanisms.

High alcohol intake

Limited information is currently available on age differences in the relationship between alcohol intake and glomerular filtration function. The relationship between alcohol consumption and a rapid eGFR decline remains controversial; it has been identified as a protective [19, 40] or as a risk factor [34]. In the present study, a high alcohol intake appeared to be a protective factor in adults aged 40–59 years in the baseline eGFR 30–59 subgroup. However, the results of the sex-stratified subgroup analysis showed a protective relationship between a high alcohol intake and rapid eGFR decline in males aged 40–59 years only (S2 Table). In consideration of increases in blood flow caused by alcohol intake among younger males resulting in temporary renal hyperfiltration [41, 42], we suspect that the long-term renal outcome of high alcohol intake needs to be confirmed with a longer follow-up. The present results provide additional evidence for a high alcohol intake being associated with an increased risk of a rapid eGFR decline in females aged 60–74 years.

Limitations and strengths

There are some limitations that need to be addressed. Since the present study only involved a two-year follow-up, we were unable to identify a transient decline in eGFR. Therefore, a long-term follow-up period is needed. Moreover, lifestyle risk factors were assessed using a self-administered questionnaire, which may have a recall bias. Additionally, we were not able to consider all possible factors impacting diabetic kidney disease including albuminuria and all the glycemic indicators from the limitations of Japanese specific health checkups items. In our study, we adjusted for broader categories of "antihypertensive medications" and "antidiabetic medications," which included drugs such as ACEIs, ARBs, SGLT2 inhibitors, and GLP-1Ras, known for their unique renoprotective effects. Future studies might benefit from investigating the renoprotective effects of these specific drugs separately. Furthermore, the coverage of data in the present study was limited by the response rate to the health examination. Approximately 54.7% adults received a specific health checkup in 2018 and 53.4% in 2020 [43], which may have caused a bias because those who attend specific health checkups are generally more health conscious. However, we argue that this is also a strength: by utilizing a very large national database, our data encompass approximately 50% of the Japanese adult population aged 40 and above, including treated and untreated subjects.

Conclusions

This is the largest available prospective study on lifestyle risk factors for a rapid eGFR decline among Japanese individuals aged 40–74 years with treated/untreated type 2 diabetes. We confirmed that relationships between lifestyles (skipping breakfast, regular smoking, a lack of habitual exercise, late-night dinners, non-refreshing sleep, and a high alcohol intake) and an increased risk of a rapid eGFR decline varied by baseline eGFR levels, age, and sex. Lifestyle modifications may effectively prevent the aggravation of diabetic kidney disease. However, the underlying mechanisms remain unclear and, thus, warrant further study.

Supporting information

S1 Table. A copy of the standard questionnaire for specific health checkups developed by the MHLW (relevant questions only).

https://doi.org/10.1371/journal.pone.0295235.s001

(DOCX)

S2 Table. Comparison of relationships between lifestyle risk factors and a rapid eGFR decline in adults with type 2 diabetes among different baseline eGFR levels and sex groups.

https://doi.org/10.1371/journal.pone.0295235.s002

(DOCX)

S3 Table. Comparison of relationships between lifestyle risk factors and a rapid eGFR decline in adults with type 2 diabetes among different baseline eGFR levels and urine protein groups.

https://doi.org/10.1371/journal.pone.0295235.s003

(DOCX)

S4 Table. Relationships between lifestyle risk scores and a rapid eGFR decline in adults with type 2 diabetes and different baseline eGFR levels.

https://doi.org/10.1371/journal.pone.0295235.s004

(DOCX)

S5 Table. Multivariate analysis of lifestyle factors for combined categories of a cardiovascular event and rapid eGFR decline.

https://doi.org/10.1371/journal.pone.0295235.s005

(DOCX)

S6 Table. Relationships between lifestyle risk factors and different eGFR decline progression (reference: Minimal progression) in adults with type 2 diabetes.

https://doi.org/10.1371/journal.pone.0295235.s006

(DOCX)

Acknowledgments

The authors would like to acknowledge and sincerely appreciate Professor Kohjiro Ueki and Dr. Takumi Hirata for their valuable advice on the study.

References

  1. 1. IDF Diabetes Atlas. International Diabetes Federation. 10th edn. Brussels: Belgium: International Diabetes Federation; 2021.
  2. 2. Kidney and diabetes [Internet]. [cited 2022 Jun 12];Available from: https://www.idf.org/our-activities/care-prevention/diabetes-and-the-kidney.html
  3. 3. Norio H, Masanori A, Nobuhiko J, et al. 2020 Annual Dialysis Data Report, JSDT Renal Data Registry[in Japanese]. journal of japanese society for dialysis therapy 2021;54(12):611–57.
  4. 4. Tokumaru T, Toyama T, Hara A, et al. Association between Unhealthy Dietary Habits and Proteinuria Onset in a Japanese General Population: A Retrospective Cohort Study. Nutrients 2020;12(9).
  5. 5. Michishita R, Matsuda T, Kawakami S, et al. The accumulation of healthy lifestyle behaviors prevents the incidence of chronic kidney disease (CKD) in middle-aged and older males. Environ Health Prev Med 2016;21(3):129–37. pmid:26797823
  6. 6. Ikegami N, Yoo B-K, Hashimoto H, et al. Japanese universal health coverage: evolution, achievements, and challenges. The Lancet 2011;378(9796):1106–15. pmid:21885107
  7. 7. Okumura Y, Sakata N, Takahashi K, Nishi D, Tachimori H. Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: An exploratory descriptive study using a nationwide claims database. J Epidemiol 2017;27(8):373–80. pmid:28242045
  8. 8. MHLW. Survey on National Health Insurance Coverage and Benefits for Foreign Residents [Internet]. Ministry of Health, Labour and Welfare; 2019. Available from: https://www.mhlw.go.jp/content/12401000/000517334.pdf
  9. 9. Matsuo S, Imai E, Horio M, et al. Revised Equations for Estimated GFR From Serum Creatinine in Japan. American Journal of Kidney Diseases 2009;53(6):982–92. pmid:19339088
  10. 10. Hayashi K, Takayama M, Abe T, et al. Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD. J Atheroscler Thromb 2017;24(8):863–75. pmid:28123142
  11. 11. Ministry of Health, Labour and Welfare. Questionnaire on specific health examination [Internet]. Available from: http://www.shigakokuho.or.jp/cmsfiles/contents/0000000/60/englishi(H30kara).pdf
  12. 12. Farshchi HR, Taylor MA, Macdonald IA. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr 2005;81(2):388–96. pmid:15699226
  13. 13. Xia J, Wang L, Ma Z, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant 2017;32(3):475–87. pmid:28339863
  14. 14. Orth SR, Hallan SI. Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence? CJASN 2008;3(1):226–36. pmid:18003763
  15. 15. Sakai R, Hashimoto Y, Ushigome E, et al. Late-night-dinner is associated with poor glycemic control in people with type 2 diabetes: The KAMOGAWA-DM cohort study. Endocr J 2018;65(4):395–402. pmid:29375081
  16. 16. Odegaard AO, Jacobs DR, Steffen LM, Van Horn L, Ludwig DS, Pereira MA. Breakfast Frequency and Development of Metabolic Risk. Diabetes Care 2013;36(10):3100–6. pmid:23775814
  17. 17. Chang P-Y, Lyu S-Y, Lin Y-F, Huang C-C. High Level of Physical Activity Reduces the Risk of Renal Progression in Hypertensive Patients. Int J Environ Res Public Health 2020;17(5):E1669. pmid:32143399
  18. 18. Turek NF, Ricardo AC, Lash JP. Sleep Disturbances as Nontraditional Risk Factors for Development and Progression of CKD: Review of the Evidence. American Journal of Kidney Diseases 2012;60(5):823–33. pmid:22727724
  19. 19. Tanaka A, Yamaguchi M, Ishimoto T, et al. Association of alcohol consumption with the incidence of proteinuria and chronic kidney disease: a retrospective cohort study in Japan. Nutr J 2022;21(1):31. pmid:35562759
  20. 20. Okada Y, Uehara S, Shibata M, et al. Habitual Alcohol Intake Modifies Relationship of Uric Acid to Incident Chronic Kidney Disease. Am J Nephrol 2019;50(1):55–62. pmid:31170706
  21. 21. Kelly JT, Su G, Zhang L, et al. Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol 2021;32(1):239–53. pmid:32868398
  22. 22. Okada R, Tsushita K, Wakai K, Kato K, Wada T, Shinohara Y. Healthy lifestyle reduces incidence of trace/positive proteinuria and rapid kidney function decline after 2 years: from the Japan Ningen Dock study. Nephrol Dial Transplant 2021;36(6):1039–48. pmid:33247759
  23. 23. Kutsuma A, Nakajima K, Suwa K. Potential Association between Breakfast Skipping and Concomitant Late-Night-Dinner Eating with Metabolic Syndrome and Proteinuria in the Japanese Population. Scientifica (Cairo) 2014;2014:253581. pmid:24982814
  24. 24. Mekary RA, Giovannucci E, Willett WC, van Dam RM, Hu FB. Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking. The American Journal of Clinical Nutrition 2012;95(5):1182–9. pmid:22456660
  25. 25. Kobayashi F, Ogata H, Omi N, et al. Effect of breakfast skipping on diurnal variation of energy metabolism and blood glucose. Obesity Research & Clinical Practice 2014;8(3):e249–57. pmid:24847666
  26. 26. Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial. Diabetes Care 2015;38(10):1820–6. pmid:26220945
  27. 27. Kim YJ, Yoon JH, Choi HS, et al. Meal Frequency and Skipping Breakfast Are Associated with Chronic Kidney Disease. Nutrients 2020;12(2):331. pmid:32012653
  28. 28. Japanese Society of Nephrology. Evidence-based Clinical Practice Guideline for CKD 2018 [in Japanese] [Internet]. 2018 [cited 2022 Jun 7];Available from: https://minds.jcqhc.or.jp/docs/gl_pdf/G0001093/4/CKD.pdf
  29. 29. Ohkuma T, Nakamura U, Iwase M, et al. Effects of smoking and its cessation on creatinine- and cystatin C-based estimated glomerular filtration rates and albuminuria in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Hypertens Res 2016;39(10):744–51. pmid:27250568
  30. 30. Yeom H, Lee JH, Kim HC, Suh I. The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population. J Prev Med Public Health 2016;49(2):108–17. pmid:27055547
  31. 31. Duncan MS, Freiberg MS, Greevy RA Jr, Kundu S, Vasan RS, Tindle HA. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA 2019;322(7):642–50. pmid:31429895
  32. 32. Bjornstad P, Cree-Green M, Baumgartner A, et al. Renal Function Is Associated With Peak Exercise Capacity in Adolescents With Type 1 Diabetes. Diabetes Care 2015;38(1):126–31. pmid:25414156
  33. 33. Stewart KJ. Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health. JAMA 2002;288(13):1622. pmid:12350193
  34. 34. Kanda E, Muneyuki T, Suwa K, Nakajima K. Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study. PLoS One 2015;10(8):e0134937. pmid:26237314
  35. 35. Michishita R, Matsuda T, Kawakami S, et al. The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol 2017;27(8):389–97.
  36. 36. Kanbay M, Copur S, Demiray A, Tuttler KR. Cardiorenal Metabolic Consequences of Nighttime Snacking: Is it an Innocent Eating Behavior? Curr Nutr Rep 2022; pmid:35195849
  37. 37. Guo X, Yu S, Li Z, et al. Self-reported sleep duration is associated with reduced glomerular filtration rate among adults with hypertension: a population-based study from rural northeast China. J Sleep Res 2015;24(3):351–8. pmid:25626914
  38. 38. Yamamoto R, Shinzawa M, Isaka Y, et al. Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD. CJASN 2018;13(12):1825–32. pmid:30442866
  39. 39. Bo Y, Yeoh E, Guo C, et al. Sleep and the Risk of Chronic Kidney Disease: A Cohort Study. Journal of Clinical Sleep Medicine 15(03):393–400. pmid:30853043
  40. 40. Sato Y, Yoshihisa A, Maki T, Takeishi Y. Effects of daily alcohol intake on glomerular filtration rate over three years. Fukushima J Med Sci 2021;67(1):1–7. pmid:33408305
  41. 41. Lin M, Su Q, Huang H, et al. Alcohol consumption and the risk for renal hyperfiltration in the general Chinese population. Eur J Clin Nutr 2017;71(4):500–5. pmid:27804962
  42. 42. Lin M, Su Q, Wen J, et al. Self-reported sleep duration and daytime napping are associated with renal hyperfiltration in general population. Sleep Breath 2018;22(1):223–32. pmid:28238100
  43. 43. About Specific Health Checkups [Internet]. [cited 2022 Aug 22];Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000161103.html